IL17A and neoplasm: Interestingly, infiltration of CT26 and A20 tumours by γδT17 as well as serum IL-17A concentration were all greatly reduced following anti-BTNL2 mAb treatment compared to treatment with isotype control antibody (Fig. 2a, b).